A pilot study of the pharmacokinetics of the modified-release once-daily tacrolimus formulation administered to living-donor liver transplant recipients

  • Song G.-W.; 
  • Lee S.-G.; 
  • Hwang S.; 
  • Kim K.-H.; 
  • Kim W.-J.; 
  • 외 3명
Citations

WEB OF SCIENCE

5
Citations

SCOPUS

5

초록

Objectives: Sustained-release once-daily tacrolimus pharmacokinetics have not yet been characterized in de novo living-donor liver transplant recipients. Here, a 12-week, phase IV, single center, open-label, pros -pective pilot study was conducted to investigate the pharmacokinetics of this formulation in these patients. Materials and Methods: Patients received continuous intravenous infusion of tacrolimus on days 0 to 5 after transplant, which was followed by oral once-daily sustained-release tacrolimus. Two 24-hour pharma -cokinetics profiles were generated for 10 patients on days 6 and 14. Secondary endpoints were minimum (trough level) and maximum whole blood concent -rations, time to maximum concentration, and incidences of acute rejection, patient and graft survival, and adverse events. Results: Mean doses (± standard deviation) of sustained-release tacrolimus on days 6 and 14 were 0.14 ± 0.03 and 0.17 ± 0.04 mg/kg. Levels were within the recommended range throughout the study. When the actual dose was examined, area under the curve from 0 to 24 hours on day 14 was 1.8-fold higher than that on day 6 (423.9 vs 235.7 ng × h/mL). When tacrolimus was normalized to 0.1 mg/kg, area under the curve from 0 to 24 hours on day 14 was 1.5-fold higher than on day 6 (279.3 vs 183.4 ng × h/mL). When we used the actual dose, we found the correlation coefficient between area under the curve from 0 to 24 hours and trough level to be higher on day 6 (r = 0.87) than on day 14 (r = 0.691). No acute rejections, graft losses, patient deaths, or drug-related adverse events were reported. Conclusions: Initial intravenous followed by sustained-release tacrolimus was safe and efficacious in living-donor liver transplant recipients. The mean area under the curve from 0 to 24 hours on day 14 was higher than previously reported; this difference may reflect cautious dosing regimens. © Başkent University 2016 Printed in Turkey. All Rights Reserved.

키워드

Drug-level monitoring; Immunosuppression; Prolonged release; creatinine; tacrolimus; calcineurin inhibitor; delayed release formulation; immunosuppressive agent; tacrolimus; acute graft rejection; adult; area under the curve; Article; clinical article; continuous infusion; creatinine blood level; death; drug efficacy; drug safety; female; graft failure; graft recipient; graft survival; human; hyperkalemia; hypomagnesemia; immunoprophylaxis; immunosuppressive treatment; liver graft; living donor; male; maximum plasma concentration; minimum plasma concentration; phase 4 clinical trial; pilot study; prospective study; sustained drug release; sustained release formulation; time to maximum plasma concentration; adverse effects; biological model; blood; clinical trial; delayed release formulation; dose calculation; drug administration; drug effects; drug formulation; drug monitoring; graft rejection; immunology; intravenous drug administration; liver transplantation; living donor; middle aged; oral drug administration; procedures; South Korea; treatment outcome; Administration, Oral; Area Under Curve; Calcineurin Inhibitors; Delayed-Action Preparations; Drug Administration Schedule; Drug Compounding; Drug Dosage Calculations; Drug Monitoring; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infusions, Intravenous; Liver Transplantation; Living Donors; Male; Middle Aged; Models, Biological; Pilot Projects; Prospective Studies; Republic of Korea; Tacrolimus; Treatment Outcome
제목
A pilot study of the pharmacokinetics of the modified-release once-daily tacrolimus formulation administered to living-donor liver transplant recipients
저자
Song G.-W.; Lee S.-G.; Hwang S.; Kim K.-H.; Kim W.-J.; Sin M.-H.; Yoon Y.-I.; Tak E.-Y.
DOI
10.6002/ect.2015.0227
발행일
2016-08
유형
Article
저널명
Experimental and Clinical Transplantation
권
14
호
4
페이지
412 ~ 418